杨天真，瘦了107斤！

Core Viewpoint - The article discusses the weight loss journey of Yang Tianzhen, highlighting her recent physical transformation and the methods she employed, including exercise and dietary changes, while clarifying that her weight loss is not solely due to traditional dieting methods [4][8]. Group 1: Yang Tianzhen's Weight Loss Journey - Yang Tianzhen has recently shared her weight loss progress, showcasing her commitment to exercise, particularly badminton, which has resulted in visible muscle definition [2][7]. - Despite public admiration for her efforts, there are mixed reactions, with some questioning the authenticity of her weight loss and others noting her previous statements against dieting [4]. - Yang underwent gastric surgery five years ago to manage diabetes, emphasizing that her primary motivation for the surgery was health-related rather than weight loss [4][5]. Group 2: Celebrity Weight Loss Trends - The article notes a surge in weight loss stories among celebrities, with many utilizing medications like Semaglutide and Tirzepatide for weight management [9]. - Elon Musk reported a weight loss of 30 pounds (approximately 27.2 kg) using Semaglutide [9]. - Other celebrities, including Whoopi Goldberg and Kelly Clarkson, have also shared their experiences with weight loss medications, highlighting significant weight reductions [11][13]. Group 3: Efficacy of Semaglutide - Clinical trials (STEP series) indicate that Semaglutide can lead to an average weight loss of 15% to 18% in obese patients, significantly outperforming placebo groups [21][26]. - In the STEP 1 trial, participants lost an average of 14.9% of their body weight, with over one-third losing more than 20% [23]. - The FDA approved Semaglutide for long-term weight management in adults with obesity or overweight conditions in June 2021, marking it as a significant advancement in obesity treatment [26]. Group 4: Efficacy of Tirzepatide - The SURMOUNT studies demonstrate that Tirzepatide can achieve substantial weight loss, with participants losing up to 26.6% of their body weight over 72 weeks [31]. - In the SURMOUNT-2 trial, patients with type 2 diabetes lost an average of 15.7% of their body weight, showcasing the drug's effectiveness [29]. - The FDA approved Tirzepatide for obesity treatment based on its promising results in clinical trials [30].